A panel of specialists in China has estimated a 76% increase in cases of hepatocellular carcinoma, from 0.87 million in 2022 to 1.52 million in 2050. The survival rate for this type of cancer is between 5% and 30%. Annual deaths could also increase by 81%, from 0.76 million to 1.37 million. Most cases are preventable, with 60% caused by risk factors such as fatty liver disease and hepatitis B and C virus infections.
Sources
Latest News
16:09
German Vice Chancellor Lars Klingbeil proposes a ban on the far-right AfD party.
16:06
The National Agency for Payments and Social Inspection announces the advance payment of social assistance benefits for the month of July, starting from August 7, 2026.
16:00
Călin Georgescu criticizes the transition to the euro currency, despite having deposits in the European currency.
15:58
China finalizes the excavation of the longest high-speed railway tunnel in the world, under the Yangtze River.
15:57
Volodymyr Zelensky accuses allies of not delivering enough interceptors quickly for air defense
See more news